News: St. Jude Medical Inc (STJ)

STJ on New York Consolidated

66.47USD
26 Dec 2014
Price Change (% chg)

$-0.20 (-0.30%)
Prev Close
$66.67
Open
$66.98
Day's High
$66.99
Day's Low
$66.41
Volume
527,240
Avg. Vol
1,907,773
52-wk High
$71.90
52-wk Low
$54.80

Search Stocks
Select another date:

Thu, Oct 16 2014

CORRECTED-UPDATE 2-St. Jude Medical lowers forecast; shares fall

(Corrects low end of pvs revenue forecast and U.S. pacemaker and defibrillator growth in 4th and 9th paragraphs)

St. Jude Medical lowers forecast; shares fall

- Heart device maker St. Jude Medical Inc on Wednesday forecast fourth-quarter revenue below Wall Street estimates, citing soft international sales and unfavorable foreign exchange rates, and its shares fell nearly 4 percent.

UPDATE 2-St. Jude Medical lowers forecast; shares fall

(Adds CFO, analyst comment, full-year forecast; updates shares)

St.Jude Medical adjusted profit rises

Oct 15 - Heart device maker St. Jude Medical Inc reported a lower quarterly profit, as it took a $39 million charge related to impairment and restructuring, despite a rise in sales of its devices to treat abnormal heart rhythms.

Fitch Affirms St. Jude Medical's at 'A'; Outlook Stable

(The following statement was released by the rating agency) CHICAGO, August 20 (Fitch) Fitch Ratings has affirmed St. Jude Medical, Inc.'s (STJ) Issuer Default Rating (IDR) at 'A' with a Stable Rating Outlook. Fitch has also affirmed the company's short-term IDR at 'F1'. A full list of Fitch's rating actions is available at the end of this release. The ratings apply to approximately $4.21 billion of debt outstanding as of June 28, 2014. KEY RATING DRIVERS Fitch's rating actions reflect the f

St. Jude not keen to join inversion deal craze

- Heart device maker St. Jude Medical Inc STJ.N said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not seeking the type of "inversion" deal increasingly popular among U.S. companies seeking to lower taxes by re-basing abroad.

UPDATE 2-St. Jude not keen to join inversion deal craze

July 16 - Heart device maker St. Jude Medical Inc said it has no plans to jump on the consolidation bandwagon that has swept the healthcare sector in recent months and is not seeking the type of "inversion" deal increasingly popular among U.S. companies seeking to lower taxes by re-basing abroad.

St Jude Medical's quarterly profit doubles as expenses fall

July 16 - Heart device maker St. Jude Medical Inc reported a quarterly net profit that more than doubled as expenses fell.

CORRECTED-UPDATE 1-FDA says manufacturing issues at St. Jude plant resolved

(Corrects second paragraph to remove reference to "Riata" leads)

CORRECTED-FDA says manufacturing issues at St. Jude plant resolved

(Corrects second paragraph to remove reference to "Riata" leads)

Select another date:
Search Stocks